Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Pharmacogenetics Stories

2013-03-08 23:04:16

This new Personalized Medicine Report delivers the latest and most up to date data on the personalized medicine market. This market research report also profiles 279 companies with estimates to 2021. Dublin, Ireland (PRWEB) March 08, 2013 Research and Markets has announced the addition of Jain PharmaBiotech's new report "Personalized Medicine - Scientific and Commercial Aspects" to their offering. The aim of this personalized medicine market research report or individualized treatment is to...

2012-09-05 06:29:14

SAN DIEGO, Sept. 5, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain and/or addiction, announced today the launch of Millennium Pharmacogenetic Testing (PGT) at PAINWeek® 2012 in Las Vegas. Millennium PGT is saliva based testing used to detect genetic variations in enzymes associated with the metabolism of medications commonly prescribed to patients suffering from...

2012-08-21 02:26:59

SAN DIEGO, Aug. 21, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain, announced today that it has initiated a first-of-its-kind, large-scale prospective clinical outcomes study of its pharmacogenetic test. The study, which will encompass more than 30 practice sites nationally, is designed to evaluate the relationship between CYP genotype, as determined by Millennium...

2012-08-16 10:23:48

FARMINGTON, Conn., Aug. 16, 2012 /PRNewswire-iReach/ -- "Personalized" cancer care has never had it better, and three drugs have been responsible for confirming their prospects to combat certain common cancers. Of these, two studies have focused on drugs for treating advanced melanoma, and a third study has explored a gene-targeted chemotherapy for a subset of lung cancers. All the three drugs have proved their efficacy in Phase III trials, and tailored medications similar to these are...

2012-08-01 06:24:51

SEATTLE, Aug. 1, 2012 /PRNewswire/ -- Genelex Corporation today announced the acceptance of US Patent 8,099,298 titled, "Genetic Data Analysis and Database Tools." Genelex's patent, filed in early 2007, covers a variety of innovations for genetic analysis and interpretation, personalized prescribing, electronic medical records processing, and online reimbursement. Notably covered are the algorithms which analyze and interpret patient specific pharmacogenetic and pharmacological...

2012-06-28 10:25:43

SAN DIEGO, June 28, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain, announced today the introduction of Millennium Pharmacogenetic Testing (PGT). Millennium PGT is saliva-based testing to detect genetic variations in enzymes associated with the metabolism of medications commonly prescribed to patients suffering from debilitating chronic pain and pain-related effects. This...

2012-06-21 10:25:55

MORRISVILLE, N.C., June 21, 2012 /PRNewswire/ -- Gentris® Corporation (www.gentris.com), a global leader in the application of genomic biomarkers to clinical studies, announced today that it has signed a Memorandum of Understanding with the Shanghai Institutes of Preventative Medicine to advance global personalized medicine. The goal of this USA-China collaboration is to create translational research and epidemiological projects, as well as training and education programs, focused on...

2012-01-27 10:32:21

Findings could lead to a screening test Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the way for a genetic screening test to determine who can safely take these drugs. The study appears in the online version of the journal The Oncologist. Oral bisphosphonates are...

2011-09-07 09:08:00

CINCINNATI, Sept. 7, 2011 /PRNewswire/ -- AssureRx Health, Inc., today announced three additions to its senior management team. These additions coincide with increasing adoption of GeneSightRx® pharmacogenetic testing aimed at assisting healthcare providers manage side effects and drug selection for patients requiring antidepressant or antipsychotic medication therapy. "We are encouraged by the rapid adoption and positive feedback from psychiatrists and other prescribers...

2011-06-09 07:24:00

LONDON, June 9, 2011 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain. To be held on 8-9th November 20111, in Windsor, UK, the theme for this year's conference is 'Stratified Medicine: Making It Happen'. Topical issues will be discussed and debated with...